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Background
We previously demonstrated that vaccine prime with a
recombinant replication-competent modified vaccinia
Tiantan (rMVTTSIVgpe) was able to enhance the boost
effects of a rAd5SIVgpe for eliciting protective immunity
against SIV mucosal challenge in rhesus macaques.
Whether this heterologous prime and boost regimen is
able to elicit potent mucosal immunity specific to SIV
remains less understood.
Methods
Different groups of mice were immunized with the fol-
lowing regiments: rMVTTSIVgpe-rAd5SIVgpe, rAd5-
SIVgpe-rMVTTSIVgpe and rAd5SIVgpe-rAd5SIVgpe.
rMVTTSIVgpe was administrated through intraoral and
intranasal routes (ioin) routes whereas rAd5SIVgpe was
given through the intramuscular injection (im).
Results
Consistent with previous findings in macaques, mice
immunized with the rMVTTSIVgpe-rAd5SIVgpe regimen
generated significantly stronger systemic cellular immune
responses as well as serum antibody responses than any
other vaccine regimens. Furthermore, as compared with
other groups, this rMVTTSIVgpe-rAd5SIVgpe regimen
induced significantly higher frequencies of gut-homing
CCR9+ Gag-specific CD8+ T cells as well as CCR6+ Gag-
specific CD4+ and CD8+ T cells. This regimen also eli-
cited the highest level of CD8+ T cell ELIspot responses
against Gag, Pol and Env antigens in mesenteric lymph
nodes (mLN). Besides, SIV-specific IgGs could be detected
in the rectal wash of mice received rMVTTSIVgpe-rAd5-
SIVgpe immunization with detectable neutralizing activity.
Conclusion
These findings demonstrated that mucosal priming with
rMVTTSIVgpe significantly promoted mucosal immunity
against SIV, which may have implications to the effective-
ness of the mucosal rMVTTSIVgpe prime-systemic rAd5-
SIVgpe boost vacciniation strategy in preventing mucosal
infection of SIVmac239 in macaques.
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